Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$119.87 - $145.67 $1.16 Million - $1.41 Million
-9,700 Closed
0 $0
Q3 2021

Oct 19, 2021

BUY
$128.64 - $184.79 $1.25 Million - $1.79 Million
9,700 New
9,700 $1.26 Million
Q2 2020

Jul 09, 2020

SELL
$95.68 - $121.88 $755,872 - $962,852
-7,900 Closed
0 $0
Q1 2020

Apr 07, 2020

BUY
$87.74 - $152.74 $693,146 - $1.21 Million
7,900 New
7,900 $787,000
Q3 2019

Oct 09, 2019

SELL
$125.18 - $143.24 $1.05 Million - $1.2 Million
-8,350 Closed
0 $0
Q2 2019

Jul 17, 2019

BUY
$125.55 - $144.48 $1.05 Million - $1.21 Million
8,350 New
8,350 $1.19 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Polianta LTD Portfolio

Follow Polianta LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polianta LTD with notifications on news.